Company intelligence / Profile preview
Boehringer Ingelheim
Ingelheim am Rhein, Germanyboehringer-ingelheim.com ↗
- Ownership
- Private
- Employees
- ~50000
- Development stage
- Commercial
01
Overview
Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, active since its founding in Germany in 1885. It remains family-owned and operates globally with about $20 billion annual revenue. The company develops therapies for human pharmaceuticals—including top-selling drugs like Spiriva® for COPD/asthma, Pradaxa® for anticoagulation, Jardiance® for diabetes/heart failure—and maintains a major presence in animal health following its acquisition of Merial. Its R&D pipeline spans cardiometabolic disease, oncology/immuno-oncology, respiratory medicine, immunology/CNS disorders, retinal health as well as vaccines and treatments for animals.
- Therapeutic areas
- PulmonologyOncologyImmunologyCardiovascularOphthalmologyNeurologyInfectious Diseases
- Modalities
- Small molecules (e.g., cardiovascular, metabolic drugs)Biologics/biopharmaceuticals (e.g., mAbs, cell culture products)Vaccines (especially in animal health)
- Industry
- Pharma
02
Drug pipeline
60 assets59 more assets in the full pipeline.
Request access →03
Partnerships
Genentech/Roche (co-founded Research Institute of Molecular Pathology Vienna)Academic collaborations globallyVarious pharma partnerships to co-develop or commercialize therapies
Beyond the preview
Go deeper on Boehringer Ingelheim.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Boehringer Ingelheim.